"10.1371_journal.pone.0148840","plos one","2016-02-12T00:00:00Z","Helene Daniels-Treffandier; Karlijn de Nie; Leanne Marsay; Christina Dold; Manish Sadarangani; Arturo Reyes-Sandoval; Paul R Langford; David Wyllie; Fergal Hill; Andrew J Pollard; Christine S Rollier","Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and The NIHR Oxford Biomedical Research Centre, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, OX3 7LE, United Kingdom; The Jenner Institute, University of Oxford, Centre for Cellular and Molecular Physiology, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, United Kingdom; Section of Paediatrics, St Marys Campus, Imperial College, London, W2 1PG, United Kingdom; Imaxio, 99 rue de Gerland, 69007, Lyon, France","Conceived and designed the experiments: HD MS AR PRL DW FH AJP CR. Performed the experiments: HD Kd LM CD CR. Analyzed the data: HD Kd LM CD DW AJP CR. Contributed reagents/materials/analysis tools: HD MS LM CD PRL DW FH AJP CR. Wrote the paper: HD MS LM CD AR PRL DW FH AJP CR.","AJP has previously conducted clinical trials on behalf of Oxford University funded by manufacturers of meningococcal vaccines. Fergal Hill is employed by Imaxio. There are no patents, products in development or marketed products to declare in relation with this study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Helene Daniels-Treffandier","HDT",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
